Dar Al Dawa Development and Investment Co. Ltd. (ASE: DADI)
Health Care · Pharmaceuticals · JO
JD1.22
+4.27% today · +3.4% 1Y
Dar Al Dawa Development and Investment Co. Ltd. (ASE: DADI) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $86.05M.
Over the last twelve months the share price has gained 3.4%, trading between 1.09 and 1.31.
Tweenvest scores Dar Al Dawa Development and Investment Co. Ltd. across four factors: quality 57/100, value 74/100, dividend 90/100. Its strongest factor is dividend.
DADI price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $86.05M
- Revenue (TTM)
- $113.76M
- P/E
- 7.45
- EPS
- 0.16
- Dividend yield
- 2.46%
- Beta (5Y)
- 0.20
- 52-week high
- JD1.31
- 52-week low
- JD1.09
- Avg volume (3M)
- —
- Shares outstanding
- 50.00M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,230.25 | -1.34% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $273.16 | +0.04% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $156.47 | +3.86% |
| Roche Holding AGSWX: ROP | $368.80B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $28.55 | +2.07% |
Figures last refreshed Aug 18, 2026.